Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ILDR Combined With ICIs and Chemotherapy for Liver Metastases From Solid Tumors
NCT07875465Phase 2Not yet recruiting
- Start
- Oct 2026
- Primary completion
- Apr 2029
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in liver metastasis. Primary endpoint: Objective Response Rate of Liver Metastases. Planned start Oct 2026; status: not yet recruiting.
02
Conditions
liver metastasis
Beyond the preview
Go deeper on NCT07875465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07875465.